4 November 2025
Latham & Watkins Advises Clario in US$8.875 Billion Sale to Thermo Fisher Scientific
Advising firms
Deal team
55 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| David Beller Lead | Latham & Watkins LLP | Partner | corporate | New York |
| Leah Sauter Lead | Latham & Watkins LLP | Partner | corporate | New York |
| Marc Klepner | Latham & Watkins LLP | Associate | corporate | Not stated |
| Miles Gilhuly | Latham & Watkins LLP | Associate | corporate | Not stated |
| Jack Katzenstein | Latham & Watkins LLP | Associate | corporate | Not stated |
| Owen Brody | Latham & Watkins LLP | Associate | corporate | Not stated |
| Thomas Forschbach | Latham & Watkins LLP | Partner | UK corporate law | London |
| Ross Allardice | Latham & Watkins LLP | Partner | UK corporate law | London |
| Maarten Overmars | Latham & Watkins LLP | Partner | UK corporate law | London |
| Nick Fisher | Latham & Watkins LLP | Associate | UK corporate law | London |
| Darragh Hyland | Latham & Watkins LLP | Associate | UK corporate law | London |
| Marc Jaffe | Latham & Watkins LLP | Partner | capital markets | New York |
| Ian Schuman | Latham & Watkins LLP | Partner | capital markets | New York |
| Elisabeth Martin | Latham & Watkins LLP | Partner | capital markets | Boston |
| Jessica Lennon | Latham & Watkins LLP | Counsel | capital markets | Washington, D.C. |
| Amanda Farrish | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Alison Vitello | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Sophia Dilworth | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Matthew Dewitz | Latham & Watkins LLP | Partner | tax | New York |
| James Aldred | Latham & Watkins LLP | Associate | tax | Not stated |
| Adam Kestenbaum | Latham & Watkins LLP | Partner | US benefits and compensation | Washington, D.C. |
| Daniel Bop | Latham & Watkins LLP | Associate | US benefits and compensation | Not stated |
| Christina Schrantz | Latham & Watkins LLP | Associate | US benefits and compensation | Not stated |
| Sarah Gadd | Latham & Watkins LLP | Partner | UK benefits and compensation | London |
| Shaun Thompson | Latham & Watkins LLP | Counsel | UK benefits and compensation | London |
| Kristina Hufnagel | Latham & Watkins LLP | Partner | German labor and employment | Munich |
| Martina Hoelzer | Latham & Watkins LLP | Associate | German labor and employment | Not stated |
| Lisa Brabant | Latham & Watkins LLP | Counsel | real estate | New York |
| Julia McQueen | Latham & Watkins LLP | Associate | real estate | Not stated |
| Jessica Cohen | Latham & Watkins LLP | Partner | intellectual property | New York |
| Sebatian Moss | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Ece Gonulal | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Robert Blamires | Latham & Watkins LLP | Partner | US data privacy | Bay Area |
| Kathryn Parsons-Reponte | Latham & Watkins LLP | Associate | US data privacy | Not stated |
| Danielle van der Merwe | Latham & Watkins LLP | Counsel | UK data privacy | London |
| Kate Burrell | Latham & Watkins LLP | Associate | UK data privacy | Not stated |
| Edgar Lee | Latham & Watkins LLP | Associate | UK data privacy | Not stated |
| Jason Caron | Latham & Watkins LLP | Partner | healthcare regulatory | Washington, D.C. |
| Betty Pang | Latham & Watkins LLP | Partner | healthcare regulatory | Bay Area |
| Ben Haas | Latham & Watkins LLP | Partner | FDA regulatory | Washington, D.C. |
| Meryl Bartlett | Latham & Watkins LLP | Associate | FDA regulatory | Not stated |
| Evan Miller | Latham & Watkins LLP | Associate | FDA regulatory | Not stated |
| Amanda Reeves | Latham & Watkins LLP | Partner | antitrust | Washington, D.C. |
| Jana Dammann de Chapto | Latham & Watkins LLP | Partner | antitrust | Hamburg |
| Tomas Nilsson | Latham & Watkins LLP | Partner | antitrust | Brussels |
| Jason Daniels | Latham & Watkins LLP | Counsel | antitrust | Bay Area |
| Rebecca Frumento | Latham & Watkins LLP | Associate | antitrust | Not stated |
| Carla Palma | Latham & Watkins LLP | Associate | antitrust | Not stated |
| Joseph Bargnesi | Latham & Watkins LLP | Partner | anticorruption | Washington, D.C. |
| Andrew Galdes | Latham & Watkins LLP | Partner | economic sanctions and export controls | Washington, D.C. |
| Joachim Grittmann | Latham & Watkins LLP | Counsel | economic sanctions and export controls | Frankfurt |
| Eric Green | Latham & Watkins LLP | Associate | economic sanctions and export controls | Not stated |
| Kyle Jefcoat | Latham & Watkins LLP | Partner | government contracts | Washington, D.C. |
| Dennis Craythorn | Latham & Watkins LLP | Partner | public company representation | New York |
| Katherine Marren | Latham & Watkins LLP | Associate | public company representation | Not stated |
52 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 8.88bn (US$8.875 billion)
- What the figure measures
- Total transaction value
- Client
- ClarioSell-side
- Counterparties
- Thermo Fisher Scientific (Buy-side)
Astorg (Sell-side)
Nordic Capital (Sell-side)
Novo Holdings (Sell-side)
Cinven (Sell-side)